Moreover, Piqué et al. [66] found that CBX2 promotes cell proliferation in breast cancer, its overexpression causes upregulation of genes involved in cell cycle progression, and CBX2 overexpression is associated with poor 5-year survival. This evidence concerns the gene CBX2 and breast carcinoma.